Authors: BARRY CE SLAYDEN RA MLUDLI K

Citation: Ce. Barry et al., MECHANISMS OF ISONIAZID RESISTANCE IN MYCOBACTERIUM-TUBERCULOSIS, DRUG RESISTANCE UPDATES, 1(2), 1998, pp. 128-134

Authors: BARRY CE LEE RE MDLULI K SAMPSON AE SCHROEDER BG SLAYDEN RA YUAN Y

Citation: Ce. Barry et al., MYCOLIC ACIDS - STRUCTURE, BIOSYNTHESIS AND PHYSIOLOGICAL FUNCTIONS, Progress in lipid research, 37(2-3), 1998, pp. 143-179

Authors: MDLULI K SLAYDEN RA ZHU YQ RAMASWAMY S PAN X MEAD D CRANE DD MUSSER JM BARRY CE

Citation: K. Mdluli et al., INHIBITION OF A MYCOBACTERIUM-TUBERCULOSIS BETA-KETOACYL ACP SYNTHASEBY ISONIAZID, Science, 280(5369), 1998, pp. 1607-1610

Authors: SLAYDEN RA LEE RE ARMOUR JW COOPER AM ORME IM BRENNAN PJ BESRA GS

Citation: Ra. Slayden et al., ANTIMYCOBACTERIAL ACTION OF THIOLACTOMYCIN - AN INHIBITOR OF FATTY-ACID AND MYCOLIC ACID SYNTHESIS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2813-2819

Authors: MIKUSOVA K SLAYDEN RA BESRA GS BRENNAN PJ

Citation: K. Mikusova et al., BIOGENESIS OF THE MYCOBACTERIAL CELL-WALL AND THE SITE OF ACTION OF ETHAMBUTOL, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2484-2489

Authors: BESRA GS SIEVERT T LEE RE SLAYDEN RA BRENNAN PJ TAKAYAMA K

Citation: Gs. Besra et al., IDENTIFICATION OF THE APPARENT CARRIER IN MYCOLIC ACID SYNTHESIS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(26), 1994, pp. 12735-12739